Agenix
Maker of blood clot imaging product reports year end finances
Published in Healthcare Mergers, Acquisitions and Ventures Week, October 22nd, 2005
ThromboView continues to meet milestones on its path to commercialization. Agenix managing director, Don Home, said "It remains our target to complete a sales, marketing and distribution agreement with an overseas partner by the end of this calendar year".
Despite spending on ThromboView's development in 2005 rising to $5.9 million, compared to $5.4 million in 2004, Agenix reported a loss of $12 million for the year ending June 30,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- 3M Health Information Systems
Siemens teams for medical necessity content, Medicare compliance software system - Adams Respiratory Therapeutics, Inc.
Mucinex maker reports 161% increase in sales - Affymetrix, Inc.
Microarray maker updates revenue outlook - Allergan, Inc.
Botox maker promotes Jeffrey Edwards to executive VP - Allon Therapeutics, Inc.
Neuroscience company to list shares on the Toronto Stock Exchange - Applied NeuroSolutions, Inc.
Neuroscience firm reports Richard B. Stone's resignation from its board - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
